Dr. Matthew Farrelly was appointed as director of the Office of Science at the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration in March 2023. In this position, Dr. Farrelly oversees all aspects of the science related to tobacco products, their use, and the resulting morbidity and mortality that we use in making regulatory decisions to ensure they will have the greatest impact on improving public health.
